SOZO Brain Center in Nicosia has announced its partnership with brain.space®, a pioneering neurotechnology company offering Brain Data as a Service (BDaaS), enabling scalable, real-time collection and interpretation of its patients’ neurophysiological signals.
SOZO Brain Center utilises clinically validated, drug-free and non-invasive healthcare treatment technologies including tDCS, CES, TPS, MET and more, to treat a multitude of conditions, from depression to addiction and multiple sclerosis.
“Together, we aim to bridge the gap between human cognition and machine intelligence by equipping our doctors with a cutting-edge EEG diagnostic tool, the Brain Sensei device,” said SOZO Brain Center’s CEO, Matthew Papadopoulos, announcing the news. “With this, our physicians can receive detailed pre-and-post Neuromodulation Treatment reports, compare results to healthy baseline data, and get AI-generated, personalized neuromodulation treatment recommendations. This collaboration leverages brain.space's unique neurophysiological data infrastructure, ensuring that neuromodulation insights are built upon the world’s most advanced BDaaS platform.”
According to Papadopoulos, the strategic collaboration moves Cyprus closer to becoming the global data center for neuromodulation, with every SOZO-certified doctor from around the world eventually being equipped with this new system. For brain.space®, this marks another step towards standardising global brain data collection, enabling partners like SOZO Brain Center to translate real-time neurophysiology into tangible outcomes across industries.
“Stay tuned as we transform healthcare with actionable AI insights, proving how SOZO’s Neuromodulation Treatment protocols are effectively applied across different medical conditions,” Papadopoulos concluded.
What is Neuromodulation Therapy?
Neuromodulation therapy is a clinically validated, non-invasive and drug-free medical approach that harnesses the power of electrical stimulation to influence the nervous system.
By directly targeting specific neural pathways, neuromodulation can alter brain activity, reduce symptoms of neurological and mental health conditions, and promote overall well-being. Unlike traditional treatments that rely on medications, neuromodulation is a safer and more sustainable option for many patients.
Neuromodulation therapy is vigorously proven to support treatments of various neurological, chronic and mental diseases and disorders. This includes, but is NOT limited to: Depression, Migraines, Fibromyalgia, Failed Back Surgery Syndrome (FBSS), Chronic Post-Operative Pain, Anxiety Disorders, Bipolar disorder, Insomnia, Post Traumatic Stress Disorder (PTSD), Dementia, Neurodevelopmental Disorders, Parkinson’s Disease, Multiple Sclerosis, Learning Disabilities, Irritable Bowel Syndrome, Mild Cognitive Impairment (MCI), Addiction, Oncology, Attention Deficit Disorder (ADHD), Amyotrophic Lateral Sclerosis (ALS), and Alzheimer's.
